Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and ...
Pharmaceutical Technology on MSN
Takeda and Protagonist seek FDA approval for rusfertide to treat PV
Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and ...
Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
Investor's Business Daily on MSN
Alumis stock catapults more than 95% as biotech takes on J&J, Protagonist in psoriasis
Biotech stock Alumis catapulted on Tuesday after the company unveiled promising results that could help it compete against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results